2seventy Bio: Buy Rating Amidst Challenges and Growth Potential in BCMA CAR-T Therapy

TipRanksDec 6 13:58 · Ratings

2seventy Bio (TSVT) Gets a Hold From Morgan Stanley

TipRanksDec 5 23:20 · Ratings

US$8.25: That's What Analysts Think 2seventy Bio, Inc. (NASDAQ:TSVT) Is Worth After Its Latest Results

Yahoo FinanceNov 15 21:58

When Will 2seventy Bio, Inc. (NASDAQ:TSVT) Become Profitable?

Simply Wall StNov 15 20:25

2seventy Bio Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Yahoo FinanceNov 14 21:46

Goldman Sachs Maintains 2seventy Bio(TSVT.US) With Sell Rating, Maintains Target Price $2

Futu NewsNov 14 02:31 · Ratings